Dow Jones

40 211,72

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
05/01/2009	17h59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/12/2008	22h00	Business Wire	Allos Therapeutics to Present at the RBC Capital Markets 2008 Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
08/12/2008	19h15	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/12/2008	17h03	Business Wire	Allos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/12/2008	18h30	Business Wire	Two Pralatrexate Studies Presented at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/12/2008	14h00	Business Wire	Allos Therapeutics to Host Analyst and Investor Briefing on Monday, December 8, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/12/2008	22h00	Business Wire	U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/11/2008	22h00	Business Wire	U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/11/2008	23h09	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/11/2008	15h17	Business Wire	Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	23h09	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2008	22h00	Business Wire	Allos Therapeutics Reports 2008 Third Quarter Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/11/2008	14h00	Business Wire	Allos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/10/2008	21h00	Business Wire	Four Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of Hematology	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/10/2008	13h00	Business Wire	Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
01/10/2008	14h00	Business Wire	Allos Therapeutics to Present at the JMP Healthcare Focus Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/09/2008	15h05	Edgar (US Regulatory)	Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/09/2008	23h06	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/09/2008	14h00	Business Wire	Allos Therapeutics to Present at the 3rd Annual Citi Biotech Day	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/08/2008	22h00	Business Wire	Allos Therapeutics to Present at the NewsMakers in the Biotech Industry Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/08/2008	22h17	Edgar (US Regulatory)	Allos Therapeutics Inc - Amended Annual Report (10-K/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	23h30	Edgar (US Regulatory)	Allos Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	22h03	Edgar (US Regulatory)	Allos Therapeutics Inc - Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/08/2008	22h00	Business Wire	Allos Therapeutics Reports 2008 Second Quarter Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/07/2008	14h00	Business Wire	Allos Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/07/2008	14h00	Business Wire	Allos Therapeutics to Report Second Quarter 2008 Results on August 5, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/07/2008	14h00	Business Wire	Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma o	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/07/2008	14h00	Business Wire	Allos Therapeutics to Present at the Collins Stewart Fourth Annual Growth Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/06/2008	21h55	Edgar (US Regulatory)	Allos Therapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/06/2008	21h52	Edgar (US Regulatory)	Allos Therapeutics Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)